Doç. Dr. Gülten Öztürk
Est-ce votre profil ? Revendiquez-le et vérifiez vos informations.
Revendiquer le profilPersonne ↔ Maladie
Sur quelles maladies ce médecin travaille-t-il ?
-
Crises convulsives 4 publicationsSource : OpenAlex / PubMed MeSHVoir les publications
- Atrophie musculaire spinale 4 publications
- Épilepsie 3 publications
- Amyotrophies spinales de l’enfance 3 publications
- Myélite 2 publications
- Maladies neuromusculaires 2 publications
Confiance
D’où viennent ces informations ?
La source est indiquée à côté de chaque information. Si vous constatez une erreur, vous pouvez suggérer une correction.
- SpécialitéNeurologie pédiatriquesaglik.gov.trD’après la source
- ÉtablissementMarmara Üniversitesi Pendik Eğitim ve Araştırma Hastanesisaglik.gov.trD’après la source
- Sujet de travailCrises convulsivesDéduit de 4 publications · Version du modèle —D’après la source
- Publications50 publicationsOpenAlex, ORCIDD’après la source
- ORCID0000-0003-4582-5121ORCIDD’après la source
- Dernière synchronisation5 novembre 2026 10:37https://marmaraeah.saglik.gov.tr/TR-1393210/doktorlarimiz.html#gulten-ozturksaglik.gov.tr
Travaux scientifiques
Publications sur Crises convulsives
-
Neonatal-onset genetic epilepsies: Insights from a large multicentre cohort
Seizure, 2026
DOI 10.1016/j.seizure.2026.04.028 PMID 42114232 Source : OpenAlex
-
Congenital myasthenic syndromes in Türkiye: genetic and clinical spectrum revisited in a nationwide pediatric cohort
Neuromuscular Disorders, 2026
DOI 10.1016/j.nmd.2026.107399 PMID 42727323 1 citation (OpenAlex) Source : OpenAlex
-
Extreme ambient temperatures and seizure outcomes in children with epilepsy: insights from a survey in Turkey
Epilepsy & Behavior, 2026
DOI 10.1016/j.yebeh.2026.110982 PMID 41797236 1 citation (OpenAlex) Source : OpenAlex
-
Comparison of Nusinersen Monotherapy Versus Combination Therapy With Nusinersen and Onasemnogene Abeparvovec in Spinal Muscular Atrophy Type 1 Patients With Two SMN2 Copies: A Multicenter Study From Türkiye
Muscle & Nerve, 2026
DOI 10.1002/mus.70191 PMID 41757676 Source : OpenAlex
-
Effects of newborn screening and nusinersen on survival and functional outcomes in spinal muscular atrophy with two SMN2 copies: A nationwide multicentre real-world study from Turkey
European Journal of Paediatric Neurology, 2026
DOI 10.1016/j.ejpn.2026.08.003 PMID 42580234 Source : OpenAlex
-
Identification of Cerebrotendinous Xanthomatosis in High-Risk Children Using a Suspicion Index–Based Screening Strategy
Research Square, 2026
DOI 10.21203/rs.3.rs-10809714/v1 Texte intégral en libre accèsSource : OpenAlex
-
1.56P Timing of therapy in sma type 1: longitudinal clinical and real-world insights
Neuromuscular Disorders, 2026
DOI 10.1016/j.nmd.2026.106641 Source : OpenAlex
-
Personalized Management and Timing of Thymectomy in Juvenile Myasthenia Gravis: Insights from Routine Clinical Scale Use in a Single-Center Retrospective Cohort—A Case Series
Children, 2025
DOI 10.3390/children12101389 PMID 41153571 Texte intégral en libre accèsSource : OpenAlex
-
The acylcarnitine profile in patients with PKAN may mimic CPT1 deficiency.
Molecular genetics and metabolism, 2025
DOI 10.1016/j.ymgme.2025.109713 PMID 41475178 2 citations (Europe PMC) Source : ORCID
-
Does Time and Experience Matter in Pediatric Arterial Ischemic Stroke (AIS) Intervention in Patients with an Initial Clinical Presentation of Mild/Moderate Severity? Long-Term Follow-Up Experience of a Single Tertiary Clinic
Children, 2025
DOI 10.3390/children12040407 PMID 40310024 Texte intégral en libre accèsSource : ORCID